Clinical trial
Sellar, Supra-sellar and Para-sellar Region Masses: Clinical Spectrum and Imaging Features With Correlation to Histopathology and Surgical Approach: A Prospective Descriptive Study.
NCT07633860 is registered in ClinicalTrials.gov with Arab Board of Neurosurgery as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sellar, Supra-sellar and Para-sellar Region Masses: Clinical Spectrum and Imaging Features With Correlation to Histopathology and Surgical Approach: A Prospective Descriptive Study.
- Lead sponsor
- Arab Board of Neurosurgery
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2022
- Completion date
- December 1, 2025
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pituitray tumor, sellar mass